Penequinine, Penehyclidine

Overview

Penequinine, Penehyclidine is under investigation in clinical trial NCT02644876 (Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications).

Indication

⑴麻醉前给药以抑制涎腺和气道腺体分泌。 ⑵用于有机磷毒物中毒急救治疗和中毒后期或胆碱酯酶老化后维持阿托品化。但单独应用疗效差，应与酶重活化剂联合应用。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia	2024/10/03	NCT06624696	Phase 4	Recruiting	Sun Yat-sen University
Penehyclidine for Prevention of Nausea and Vomiting After Bimaxillary Surgery	2020/07/02	NCT04454866	Not Applicable	Completed	Peking University First Hospital
Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection	2020/04/03	NCT04332848	Phase 4	UNKNOWN	National Taiwan University Hospital
Penehyclidine and Postoperative Nausea and Vomiting After Bimaxillary Surgery	2019/10/02	NCT04112771	N/A	Completed	Peking University First Hospital
Penehyclidine for PONV Prophylaxis After Strabismus Surgery	2019/08/13	NCT04054479	Phase 4	Completed	The First Affiliated Hospital with Nanjing Medical University
Prophylactic Penehyclidine Hydrochloride Inhalation and 3-year Outcome After Surgery	2019/03/11	NCT03868709	Phase 4	Completed	Peking University First Hospital
Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications	2016/01/01	NCT02644876	Phase 4	Completed	Peking University First Hospital
Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients	2014/07/28	NCT02202239	Phase 4	UNKNOWN	Zhujiang Hospital

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

AI-Powered Research

Premium Access